Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Individuals experiencing food noise often describe a relentless mental commentary about what to eat, when to eat, and how much to consume
GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
For additional program details, visit our full FAQs.
Favero, G., Franceschetti, L., Bonomini, F., Rodella, L
US$ 25.01
US$ 21.87
US$ 20.01
